MED227 - Fall Quarter
Drug Development: Key Issues in Regulation, Benefit vs. Risk, and Commercialization
September 26 – December 5, 2023
This course is intended to provide an educational and practical perspective of drug development and its incredible potential, as well as challenges. Attendees can expect a blend of seminars, debates, and case study analyses to educate on key regulatory issues and commercial considerations, with an emphasis on cardiovascular applications.
This course is suitable for medical students, graduate students, basic scientists, clinicians, and clinician-scientists to provide an educational and practical perspective on the essential issues in drug development.
Please note that not all directors are available for the full Office Hours time window and the availability of individual directors may vary for specific dates.
Please contact Adrienne Mueller for Office Hour Zoom information, and indicate whether there is a specific director you would like to speak with.